Etiologically, dysfunction of microglia plays a fundamental role in AD, and in 2017 it was found that RIPK1-dependent transcription promotes disease-associated microglia and lysosomal defects to mediate the accumulation of amyloid plaques in AD. Here, RIPK1 is linked to Alzheimer disease.